$406.4 M

MDXG Mkt cap, 07-Nov-2018

$84.6 M

MiMedx Group Revenue Q3, 2017
MiMedx Group Gross profit (Q3, 2017)75 M
MiMedx Group Gross profit margin (Q3, 2017), %88.7%
MiMedx Group Net income (Q3, 2017)17.5 M
MiMedx Group EBIT (Q3, 2017)8.8 M
MiMedx Group Cash, 30-Sep-201736.5 M

MiMedx Group Revenue

MiMedx Group revenue was $245.02 m in FY, 2016 which is a 30.8% year over year increase from the previous period.

Embed Graph

MiMedx Group Revenue Breakdown

Embed Graph

MiMedx Group revenue breakdown by business segment: 24.9% from Surgical, Sports Medicine & Orthopedics (SSO) and 75.1% from Wound Care

MiMedx Group Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

59.2m118.2m187.3m245.0m

Revenue growth, %

100%58%31%

Cost of goods sold

9.3m12.7m20.2m32.4m

Gross profit

49.9m105.6m167.1m212.6m

Gross profit Margin, %

84%89%89%87%

R&D expense

4.8m8.4m12.0m

General and administrative expense

46.2m133.4m180.0m

Operating expense total

51.1m141.8m192.0m

Depreciation and amortization

1.1m933.0k2.1m

EBIT

(2.6m)7.1m24.4m18.4m

EBIT margin, %

(4%)6%13%8%

Interest expense

45.2k48.0k86.0k339.0k

Interest income

48.0k

Pre tax profit

(4.0m)7.1m24.3m18.1m

Income tax expense

(99.6k)(832.0k)5.2m

Net Income

(4.1m)6.2m29.4m12.0m

MiMedx Group Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

44.1m46.6m28.5m34.4m

Accounts Receivable

16.1m26.7m53.8m67.2m

Inventories

3.9m1.5m7.5m17.8m

Current Assets

65.4m85.7m96.3m126.5m

PP&E

4.1m5.4m9.5m13.8m

Goodwill

4.0m4.0m4.0m20.2m

Total Assets

84.7m109.3m135.9m193.3m

Accounts Payable

2.5m3.7m6.6m11.4m

Current Liabilities

9.6m18.4m26.8m50.7m

Total Liabilities

11.1m27.9m60.3m

Additional Paid-in Capital

147.3m162.4m163.1m161.3m

Retained Earnings

(73.8m)(67.6m)(38.1m)(26.2m)

Total Equity

73.6m89.3m108.0m133.0m

Financial Leverage

1.2 x1.2 x1.3 x1.5 x

MiMedx Group Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(4.1m)6.2m29.4m12.0m

Depreciation and Amortization

1.7m928.0k2.7m5.5m

Accounts Receivable

(8.4m)(11.0m)(27.1m)(11.4m)

Inventories

(858.0k)(203.0k)(2.3m)(2.8m)

Accounts Payable

1.2m1.3m3.1m(3.7m)

Cash From Operating Activities

(285.5k)16.8m18.8m25.8m

Cash From Investing Activities

(3.0m)(12.2m)(678.0k)(11.7m)

Cash From Financing Activities

40.6m(2.1m)(36.2m)(8.2m)

Income Taxes Paid

5.8m

MiMedx Group Ratios

USDY, 2017

Revenue/Employee

122.6k

Financial Leverage

1.3 x
Report incorrect company information

MiMedx Group Operating Metrics

FY, 2016

Patent Applications

110

Patents (US)

92
Report incorrect company information

MiMedx Group Employee Rating

2.852 votes
Culture & Values
2.7
Work/Life Balance
2.9
Senior Management
2.4
Salary & Benefits
3.2
Career Opportunities
2.8
Source